In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Xueting Yao; Fei Ye; Miao Zhang; Cheng Cui; Baoying Huang; Peihua Niu; Xu Liu; Li Zhao; Erdan Dong; Chunli Song

doi:https://doi.org/10.1093/cid/ciaa237

In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Authors: Xueting Yao, Fei Ye, Miao Zhang, Cheng Cui, Baoying Huang et al.

Year: 2020

HydroxychloroquineCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Severe acute respiratory syndrome coronavirusMedicine

2,766

Citations

2020

Published

Authors

Read PDF DOI